FDA Panel Endorses Authorization of Pfizer-BioNTech Vaccine for Emergency Use
AllSides Summary
Featured Coverage of this Story
From the Left
FDA advisers recommend the first Covid-19 vaccine for emergency use in the US
An advisory committee to the Food and Drug Administration has voted 17 to 4, with 1 abstention, to recommend emergency use authorization to the first vaccine for Covid-19 in the United States.
The highly anticipated vote means health workers facing high exposure to the disease and residents of long-term care facilities could start receiving the first doses of the two-dose vaccine, developed by Pfizer and BioNTech, within days. The first 6.4 million doses could be ready to ship as soon as Friday.
The Vaccines and Related Biological Products Advisory Committee...
From the Center
FDA panel recommends approval of Pfizer’s Covid vaccine for emergency use
A key Food and Drug Administration advisory panel on Thursday recommended the approval of Pfizer and BioNTech’s coronavirus vaccine for emergency use in people over 16 years old, the last step before the FDA gives the final OK to broadly distribute the first doses throughout the United States.
If the FDA accepts the nonbinding recommendation from the Vaccines and Related Biological Products Advisory Committee — which is expected — it would mark a pivotal moment in the Covid-19 pandemic, which has infected more than 15.4 million people and killed roughly...
From the Right
FDA panel endorses Pfizer coronavirus vaccine for emergency use
A U.S. Food and Drug Administration advisory panel voted Thursday to endorse the Pfizer-BioNTech coronavirus vaccine, clearing the way for FDA leaders to authorize emergency mass distribution amid an ongoing surge of COVID-19 cases across the country.
Vaccine shipments would begin within hours of the FDA’s decision, which could come by as early as Friday, with the first vaccinations to follow soon afterward. Pfizer’s vaccine will be available in limited quantities, with initial doses earmarked for frontline health care workers and high-risk patients.
In November, Pfizer announced that its coronavirus...
AllSides Picks
June 1st, 2023
May 31st, 2023
May 26th, 2023
Discuss & Debate healthcare
June 20 at 6am PT / 9am ET A Peace of my MindMore News about Coronavirus from the Left, Center and Right
From the Left
From the Center
From the Right
